Helderman JH - Search Results

1

Potential clinical implications of substitution of generic cyclosporine formulations for cyclosporine microemulsion (Neoral) in transplant recipients.

Johnston A, Belitsky P, Frei U, Horvath J, Hoyer P, Helderman JH, Oellerich M, Pollard S, Riad H, Rigotti P, Keown P, Nashan B. Johnston A, et al. Among authors: helderman jh. Eur J Clin Pharmacol. 2004 Aug;60(6):389-95. doi: 10.1007/s00228-004-0774-8. Epub 2004 Jun 17. Eur J Clin Pharmacol. 2004. PMID: 15205865 Review.

2

Healthcare costs in renal transplant recipients using branded versus generic ciclosporin.

Helderman JH, Kang N, Legorreta AP, Chen JY. Helderman JH, et al. Appl Health Econ Health Policy. 2010;8(1):61-8. doi: 10.1007/BF03256166. Appl Health Econ Health Policy. 2010. PMID: 20038194

3

Renal function in primary liver transplant recipients receiving neoral (cyclosporine) versus prograf (tacrolimus).

Van Buren D, Payne J, Geevarghese S, MacDonell R, Chapman W, Wright JK, Helderman JH, Richie R, Pinson CW. Van Buren D, et al. Among authors: helderman jh. Transplant Proc. 1998 Jun;30(4):1401-2. doi: 10.1016/s0041-1345(98)00289-9. Transplant Proc. 1998. PMID: 9636566 Clinical Trial.

4

Experience with cyclosporine.

Langone AJ, Helderman JH. Langone AJ, et al. Among authors: helderman jh. Transplant Proc. 2004 Mar;36(2 Suppl):59S-63S. doi: 10.1016/j.transproceed.2004.01.022. Transplant Proc. 2004. PMID: 15041308 Review. No abstract available.

5

Cyclosporine avoidance.

Gauthier P, Helderman JH. Gauthier P, et al. Among authors: helderman jh. J Am Soc Nephrol. 2000 Oct;11(10):1933-1936. doi: 10.1681/ASN.V11101933. J Am Soc Nephrol. 2000. PMID: 11004226 Review. No abstract available.

6

A systematic examination of estimates of cyclosporine area under the curve in renal transplant recipients.

Kazancioglu R, Goral S, Shockley SL, Feurer ID, Ramanathan V, Helderman JH, VanBuren D. Kazancioglu R, et al. Among authors: helderman jh. Transplantation. 2002 Jan 27;73(2):301-2. doi: 10.1097/00007890-200201270-00027. Transplantation. 2002. PMID: 11821749 No abstract available.

7

Impact of Sandimmune, Neoral, and Prograf on rejection incidence and renal function in primary liver transplant recipients.

Van Buren D, Payne J, Geevarghese S, MacDonell R, Chapman W, Wright JK, Helderman JH, Richie R, Pinson CW. Van Buren D, et al. Among authors: helderman jh. Transplant Proc. 1998 Aug;30(5):1830-2. doi: 10.1016/s0041-1345(98)00448-5. Transplant Proc. 1998. PMID: 9723299 Clinical Trial.

8

A pilot protocol of a calcineurin-inhibitor free regimen for kidney transplant recipients of marginal donor kidneys or with delayed graft function.

Shaffer D, Langone A, Nylander WA, Goral S, Kizilisik AT, Helderman JH. Shaffer D, et al. Among authors: helderman jh. Clin Transplant. 2003;17 Suppl 9:31-4. doi: 10.1034/j.1399-0012.17.s9.5.x. Clin Transplant. 2003. PMID: 12795665

9

Chronic immunosuppression of the renal transplant patient.

Helderman JH, Van Buren DH, Amend WJ Jr, Pirsch JD. Helderman JH, et al. J Am Soc Nephrol. 1994 Feb;4(8 Suppl):S2-9. doi: 10.1681/ASN.V48s2. J Am Soc Nephrol. 1994. PMID: 8193291 Review.

10

Drug substitution in transplantation: a National Kidney Foundation White Paper.

Sabatini S, Ferguson RM, Helderman JH, Hull AR, Kirkpatrick BS, Barr WH. Sabatini S, et al. Among authors: helderman jh. Am J Kidney Dis. 1999 Feb;33(2):389-97. doi: 10.1016/s0272-6386(99)70318-5. Am J Kidney Dis. 1999. PMID: 10023656 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

148 results

Search Page

Filters